Skip to main content
Retour
DRTS logo

Alpha Tau Medical Ltd.

Qualité des données : 100%
DRTS
NASDAQ Healthcare Biotechnology
7,20 €
▲ 0,13 € (1,84%)
Cap. Boursière : 633,67M
Fourchette du Jour
7,09 € 7,44 €
Fourchette 52 Semaines
2,30 € 8,60 €
Volume
216 513
Moyenne 50J / 200J
7,20 € / 4,62 €
Clôture Précédente
7,07 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique Action Médiane du Secteur
P/E -14,9 0,4
P/B 8,2 2,9
ROE % -61,0 3,7
Net Margin % 3,8
Rev Growth 5Y % 10,0
D/E 0,2 0,2

Points Clés

Debt/Equity of 0,18 — conservative balance sheet
Negative free cash flow of -32,76M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-61,00%
ROIC-34,92%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
0,18
Current Ratio7,45
Interest Coverage-100,93

Valorisation

P/E Ratio
-14,87
P/B Ratio8,22
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -42,63M
ROE -61,00% ROA -40,00%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -32,76M
ROIC -34,92% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,18 Current Ratio 7,45
Interest Coverage -100,93 Dividend Yield 0,00%
Valuation
P/E Ratio -14,87 P/B Ratio 8,22
P/S Ratio N/A PEG Ratio -0,53
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 633,67M Enterprise Value 631,42M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 0,0 0,0 0,0 0,0
Net Income -42,63M -31,75M -29,16M -33,76M -27,27M
EPS (Diluted) -0,53 -0,45 -0,42 -0,53 -0,67
Gross Profit -1,23M -1,10M -1,07M -979 000,0 -776 000,0
Operating Income -42,29M -36,04M 35,68M -32,14M -13,79M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 106,58M 86,20M 107,39M 120,15M 42,22M
Total Liabilities 29,48M 23,54M 22,91M 14,49M 76,99M
Shareholders' Equity 77,10M 62,67M 84,48M 105,66M -34,78M
Total Debt 13,73M 12,54M 13,28M 5,19M 53,96M
Cash & Equivalents 15,98M 13,72M 12,66M 5,84M 23,24M
Current Assets 78,30M 64,23M 85,76M 106,48M 32,64M
Current Liabilities 10,51M 8,68M 7,10M 4,34M 4,41M